skip to Main Content
Luis A. Pérez-Romasanta, MD, PhD

Profession:

Radiation Oncologist; Associate Professor.

Institute, city, country:

Hospital Universitario de Salamanca, Salamanca, Spain
Facultad de Medicina, Universidad de Salamanca, Salamanca, Spain.

Contact details:

Servicio de Oncología Radioterápica
Hospital Universitario de Salamanca
Paseo de San Vicente, 58
37006 Salamanca
Spain
lapr@usal.es

Qualifications / Education:

  • Universidad de Navarra, Spain – MD Degree
  • Universidad de Santiago de Compostela, Spain – PhD Degree
  • Hospital 12 de Octubre, Universidad Complutense, Spain – Radiation Oncology specialization
  • Massachusetts General Hospital, Boston, USA – Clinical/Research Fellowship in Radiobiology and Radiation Oncology

Main areas of professional interest/specialisation:

Radiation Oncology

Professional experience/appointments:

  • Hospital Universitario de Valladolid, Valladolid, Spain – Staff
  • Massachusetts General Hospital, Boston, USA – Clinical/Research Fellow
  • Hospital Universitario de Santiago de Compostela, Santiago, Spain – Staff
  • Hospital do Meixoeiro, Vigo, Spain – Staff
  • Hospital General Universitario de Ciudad Real, Ciudad Real, Spain – Chairman
  • Hospital Universitario de Salamanca, Salamanca, Spain – Chairman

Research interests:

  • Radiation effects on tumour microenvironment
  • Biomathematics applied to Oncology
  • Spine metastases
  • Altered fractionation schedules in Radiotherapy
  • Patient reported outcomes

Professional membership & associations:

  • SEOR (Sociedad Española de Oncología Radioterápica)
  • ESTRO

Honours and awards:

  • Anna Hamann Fellowship (ASTRO)

Most recent international scientific publications:

Pérez-Beteta J, Martínez-González A, Molina D, Amo-Salas M, Luque B, Arregui E, Calvo M, Borrás JM, López C, Claramonte M, Barcia JA, Iglesias L, Avecillas J, Albillo D, Navarro M, Villanueva JM, Paniagua JC, Martino J, Velásquez C, Asenjo B, Benavides M, Herruzo I, Delgado MD, Del Valle A, Falkov A, Schucht P, Arana E, Pérez-Romasanta L, Pérez-García VM. Glioblastoma: does the pre-treatment geometry matter? A postcontrast T1 MRI-based study. Eur Radiol. 2017 Mar;27(3):1096-1104. doi: 10.1007/s00330-016-4453-9. Epub 2016 Jun 21. PubMed PMID: 27329522.

Molina D, Pérez-Beteta J, Luque B, Arregui E, Calvo M, Borrás JM, López C, Martino J, Velasquez C, Asenjo B, Benavides M, Herruzo I, Martínez-González A, Pérez-Romasanta L, Arana E, Pérez-García VM. Tumour heterogeneity in glioblastoma assessed by MRI texture analysis: a potential marker of survival. Br J Radiol. 2016 Jul 4:20160242. [Epub ahead of print] PubMed PMID: 27319577; PubMed Central PMCID: PMC5124892.

Arana E, Kovacs FM, Royuela A, Asenjo B, Pérez-Ramírez Ú, Zamora J; Spanish Back Pain Research Network Task Force for the Improvement of Inter-Disciplinary Management of Spinal Metastasis. Agreement in Metastatic Spinal Cord Compression. J Natl Compr Canc Netw. 2016 Jan;14(1):70-6. Epub 2016 Jan 5. PubMed PMID: 26733556.

Arana E, Kovacs FM, Royuela A, Asenjo B, Pérez-Ramírez Ú, Zamora J; Spanish Back Pain Research Network Task Force for the Improvement of Inter-Disciplinary Management of Spinal Metastasis. Spine Instability Neoplastic Score: agreement across different medical and surgical specialties. Spine J. 2016 May;16(5):591-9. doi: 10.1016/j.spinee.2015.10.006. Epub 2015 Oct 22. PubMed PMID: 26471708.

Pérez-García VM, Pérez-Romasanta LA. Extreme protraction for low-grade gliomas: theoretical proof of concept of a novel therapeutical strategy. Math Med Biol. 2016 Sep;33(3):253-71. doi: 10.1093/imammb/dqv017. Epub 2015 May 11. PubMed PMID: 25969501.

Arana E, Kovacs FM, Royuela A, Asenjo B, Pérez-Ramírez U, Zamora J; Spanish Back Pain Research Network Task Force for the improvement of inter-disciplinary management of spinal metastasis. Agreement in the assessment of metastatic spine disease using scoring systems. Radiother Oncol. 2015 Apr;115(1):135-40. doi: 10.1016/j.radonc.2015.03.016. Epub 2015 Apr 10. PubMed PMID: 25869337.

Macias VA, Perez-Romasanta LA. A clinical review on extreme hypofractionated stereotactic body radiation therapy for localized prostate cancer using
nonrobotic linear accelerators. Cancer Invest. 2014 Jun;32(5):191-6. doi: 10.3109/07357907.2014.896015. Epub 2014 Mar 21. Review. PubMed PMID: 24654695.

Martínez-González, A., Durán-Prado, M., Calvo, G. F., Alcaín, F. J., Pérez-Romasanta, L. A., & Pérez-García, V. M. (2015). Combined therapies of antithrombotics and antioxidants delay in silico brain tumour progression. Mathematical Medicine and Biology : A Journal of the IMA, 32(3), 239–62. doi:10.1093/imammb/dqu002

Pérez-García, V. M., Bogdanska, M., Martínez-González, A., Belmonte-Beitia, J., Schucht, P., & Pérez-Romasanta, L. A. (2015). Delay effects in the response of low-grade gliomas to radiotherapy: a mathematical model and its therapeutical implications. Mathematical Medicine and Biology : A Journal of the IMA, 32(3), 307–29. doi:10.1093/imammb/dqu009

Martínez-González A, Durán-Prado M, Calvo GF, Alcaín FJ, Pérez-Romasanta LA, Pérez-García VM. Combined therapies of antithrombotics and antioxidants delay in silico brain tumour progression. Math Med Biol. 2014 Feb 20. [Epub ahead of print] PubMed PMID: 24562299.

Perez-Romasanta LA, Bellon-Guardia M, Torres-Donaire J, Lozano-Martin E, Sanz-Martin M, Velasco-Jimenez J. Tumor volume delineation in head and neck cancer with 18-fluor-fluorodeoxiglucose positron emission tomography: adaptive thresholding method applied to primary tumors and metastatic lymph nodes. ClinTransl Oncol. 2013 Apr;15(4):283-93. doi: 10.1007/s12094-012-0914-z. Epub 2012 Aug 3. PubMed PMID: 22865325.

Martínez-González A, Calvo GF, Pérez Romasanta LA, Pérez-García VM. Hypoxic cell waves around necrotic cores in glioblastoma: a biomathematical model and its therapeutic implications. Bull Math Biol. 2012 Dec;74(12):2875-96. doi: 10.1007/s11538-012-9786-1. Epub 2012 Nov 14. PubMed PMID: 23151957; PubMed Central PMCID: PMC3510407.

Back To Top